LUC FRENETTE: Open Payments
NPI 1336175439 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$418 in 15 payments from 9 companies in 2025. Trend: 2023 $749 · 2024 $618 · 2025 $418
Food & beverage: $418
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 4 | $95 |
| Indivior Inc. | 3 | $94 |
| Atland Pharmaceuticals, LLC | 1 | $55 |
| SPR Therapeutics, Inc | 1 | $47 |
| Abbott Laboratories | 2 | $40 |
| Globus Medical, Inc. | 1 | $28 |
| SCILEX PHARMACEUTICALS INC. | 1 | $23 |
| Medtronic, Inc. | 1 | $22 |
| Boston Scientific Corporation | 1 | $15 |
Products named: BRIXADI, SUBLOCADE, ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE, SPRINT PNS System, PROCLAIM, Senza, ZTLido, RIALTO SI FUSION SYSTEM.
Industry payments across AL — which companies pay providers there.
